background: Male factor and idiopathic infertility contribute significantly to global infertility, with abnormal testicular gene expression considered to be a major cause. Certain types of male infertility are caused by failure of the sperm to activate the oocyte, a process normally regulated by calcium oscillations, thought to be induced by a sperm-specific phospholipase C, PLCzeta (PLCz). Previously, we identified a point mutation in an infertile male resulting in the substitution of histidine for proline at position 398 of the protein sequence (PLCz H398P ), leading to abnormal PLCz function and infertility.
Introduction
Oocyte activation, a fundamental step in the process of fertilization involving cortical granule exocytosis, prevention of polyspermy and ultimately the release of the oocyte from meiotic arrest (Whitaker, 2006) , involves elevations of intracellular calcium (Ca 2+ ) in response to cellular signalling mediated by inositol 1,4,5-triphosphate (IP 3 ) (Stricker, 1999; Whitaker, 2006; Berridge, 2009) . In mammals, this manifests as a series of characteristic Ca 2+ oscillations which begin soon after gamete fusion and persist beyond the completion of meiosis (Jones, 2005) . Mounting evidence suggests that the agent responsible for Ca 2+ oscillations within activating oocytes is a spermspecific phospholipase C, phospholipase C zeta (PLCz), located on chromosome 12 in humans Saunders et al., 2002 Saunders et al., , 2007 Knott et al., 2005; Kouchi et al., 2005; Swann et al., 2006; Parrington et al., 2007; Kashir et al., 2010) . Given the fundamental role of PLCz in activating the oocyte following gamete fusion, PLCz isoforms exhibiting abnormal expression profiles or defective functional ability, may underlie certain types of human male factor infertility in which oocyte activation is deficient (OAD). Globally, infertility is now estimated to affect one in seven couples (Evens, 2004; Boivin et al., 2007; Ombelet et al., 2008) . Intracytoplasmic sperm injection (ICSI; whereby a single sperm is micro-injected directly into the oocyte), is able to rescue fertility in 35 -40% of infertile cases (Kashir et al., 2010) . However, complete or virtually complete fertilization failure is known to occur in 1-5% of all ICSI cycles (Flaherty et al., 1998; Mahutte and Arici, 2003; Yanagida et al., 2008; Kashir et al., 2010) .
The first link between OAD and PLCz was reported by Yoon et al. (2008) , who found that sperm from patients repeatedly failing to activate oocytes via ICSI could not initiate Ca 2+ oscillations when injected into mouse oocytes, and that this was associated with abnormal expression and localization of PLCz in sperm. However, this study found no evidence of a genetic condition underlying these observations. Interestingly, the activating ability of such sperm could be rescued upon co-injection with mouse PLCz mRNA (Yoon et al., 2008) , thereby providing significant support for the idea of using PLCz as a novel therapeutic agent for OAD. Heytens et al. (2009) provided the first genetic link to PLCz deficiency by identifying a substitution mutation in an infertile male diagnosed with OAD. This mutation occurred within the Y domain of the active site at position 398 of the PLCz open reading frame (ORF), resulting in a histidine to proline substitution (PLCz H398P ).
Injection of PLCz H398P cRNA into mouse oocytes resulted in highly abnormal Ca 2+ transients that were unable to activate oocytes (Heytens et al., 2009) . Moreover, a mouse equivalent of PLCz H398P , resulting in a histidine to proline substitution at position 435 of the mouse PLCz ORF (PLCz H435P ), also lacked the ability to induce Ca 2+ oscillations in oocytes, and was defective in PLC activity (Nomikos et al., 2011) . However, a major conundrum with the Heytens et al. (2009) study was that while PLCz H398P was proposed to be heterozygous, it was unclear how it could cause infertility in the patient. Heytens et al. (2009) hypothesized that the infertile phenotype of this patient could have arisen via a dominant negative mechanism. However, the ability of PLCz H398P to act in such a manner was not clearly demonstrated by this study. Subsequently, a study of PLCz H435P showed that the injection of wild-type PLCz (PLCz WT ) elicited a normal Ca 2+ oscillation profile upon microinjection in mouse oocytes in the presence of a higher concentration (10 times) of the PLCz H435P mutant (Nomikos et al., 2011) , indicating that PLCz H398P did not act in a dominant negative manner.
Male factor infertility can arise in a number of ways, with genetic causes representing the greatest cause for concern. Moreover, some cases of idiopathic male infertility may represent the results of multiple genetic defects that disrupt spermatogenesis and testicular gene expression (for review, see Kashir et al., 2010) , indicating that assisted reproductive technology (ART) interventions such as ICSI could potentially transmit paternal fertility problems from father to son. However, prior study of such genetic causes of infertility has mostly been limited to paternal modes of inheritance, with potential maternal involvement being largely ignored.
Here, in response to concerns about the ability of PLCz H398P to act in a dominant negative fashion, and thus be capable of causing infertility in a heterozygous manner, we carried out a more thorough re-examination of the PLCz gene from the patient in which the H398P mutation was discovered. We report the identification of a second novel PLCz mutation in the patient possessing PLCz H398P , and analyse the functional effects of the new mutant form of PLCz in comparison with PLCz WT and PLCz
H398P
. Crucially, we investigate the genetic origin and mode of inheritance of PLCz mutation across three generations of the patient's family in an attempt to gain further understanding of how such mutations may exert an effect upon fertility.
Materials and Methods

Sample acquisition and processing
Genomic DNA was extracted from buccal cell samples obtained from nine infertile males whose sperm lacked activation ability, including the patient from whom PLCz H398P had been previously identified (patient H398P ; Heytens et al., 2009 
Molecular analysis of the PLCz gene
Amplicons were generated for patient
H398P
, four family members of patient H398P and eight further infertile males, by PCR using the High Fidelity Master Kit (Roche Biosciences, UK) and primer sequences/thermal cycling conditions previously described by Heytens et al. (2009) . Each exon of the PLCz gene was amplified from genomic DNA and amplicon nucleotides were sequence determined (Geneservice, UK). Sequenced amplicons were compared with the published PLCz WT ORF sequence (accession number NM_033123). In contrast to the analyses carried out by Heytens et al. (2009) , the current study aimed to investigate whether sequence anomalies were homozygous or heterozygous in nature. In order to do this, sequencing peaks were analysed using Chromas Lite freeware (Technelysium Ltd., Australia).
cRNA synthesis
PLCz WT and PLCz H398P cRNA was synthesized as described previously by Heytens et al. (2009) . PLCz H233L was created using the QuikChange SiteDirected Mutagenesis Kit (Stratagene, USA) following the manufacturer's instructions, using a molecular construct containing PLCz WT as the template (forward primer: 5 ′ -TTATCCAAGCTATACTCAAGTATGCATTCAT-3 ′ ; reverse primer: 5 ′ -ATGAATGCATACTTGAGTATAGCTTGGATAA-3 ′ ). cRNA was stored in single-use aliquots at 2808C until use.
Inheritance profiles for mutant PLCz
Mouse oocyte collection, culture and micro-injection and Ca 21 imaging
Metaphase II stage oocytes were collected, and cumulous cells removed as previously described . Denuded oocytes were placed in 50 ml drops of potassium simplex optimized medium (Specialty Media, Phillipsburg, NJ, USA) containing 0.1% polyvinyl alcohol (Sigma, USA) until injection. Oocytes were micro-injected with cRNA corresponding to PLCz WT or PLCz H233L (at two separate concentration sets:
344 and 352 ng/ml; 172 and 176 ng/ml, respectively) as described by Kurokawa et al. (2005) . Animal handling and procedures were approved by the University of Massachusetts IACUC committee. Intracellular Ca 2+ response within injected mouse oocytes was measured as previously detailed . Ca 2+ changes were registered, and filter wheel changes controlled, by SimplePCI software (C-Imaging System, Cranberry Township, PA, USA). Statistical analysis was performed using Graphpad Prism software (GraphPad, USA). Correlations between the amplitude of the first Ca 2+ peak, as well as the interval between the first and second Ca 2+ peaks following micro-injection of WT and H233L cRNA at both concentrations were determined using the t-test. Data are presented as mean + SEM and a P ≤ 0.05 was considered statistically significant.
TaqMan single-nucleotide polymorphism genotyping assay
Two genotyping assays employing sequence detection probes were developed using the 'Custom TaqMan assay design tool' (Applied Biosystems, UK) and used to screen a population of 100 fertile individuals for the presence of the H233L and H398P mutations, as well as to confirm the inheritance patterns of the H233L and H398P mutations in the patient and his family. The resultant assays were carried out using GTXpress mastermix (Applied Biosystems, UK), with thermal cycling undertaken on a StepOne real-time PCR system (Applied Biosystems, UK). This involved a pre-PCR read at 258C for 30 s, followed by a DNA polymerase activation step at 958C for 20 s. This was followed by 40 or 35 cycles (H233L and H398P, respectively) of denaturing and annealing/extension at 95 or 928C (H233L and H398P, respectively) for 3 s, and 60 or 628C (H233L and H398P, respectively) for 20 s, at the end of which another read was obtained. A post-PCR read was then obtained at 258C for 30 s. Results were analysed using StepOne v2.1 software and TaqMan Genotyper software (Applied Biosystems, UK).
Results
Identification of a second novel PLCz mutation
In addition to PLCz H398P , described previously by Heytens et al. (2009) , we identified a base change in the PLCz gene from the same infertile patient resulting in the substitution of an adenine (A) nucleotide at position 698 of the ORF sequence to a thymine (T) nucleotide, corresponding to the substitution of a histidine residue for a leucine residue in the catalytic X domain at position 233 (H233L) of the amino acid sequence (Fig. 1A) (Fig. 2) . However, injection of WT and H233L cRNA in mouse oocytes at a reduced concentration (172 and 176 ng/ml, respectively) resulted in a significantly decreased (P ≤ 0.05) amplitude of the first Ca 2+ peak following H233L cRNA injection ( 0.15 a.u) when compared with WT cRNA injection ( 0.3 a.u), as well as a significantly increased (P ≤ 0.05) interval between the first and second Ca 2+ peaks ( 20 and 110 min, respectively) following H233L when compared with WT cRNA at these concentrations (Fig. 3) .
Genetic modes of inheritance for the H233L and H398P PLCz mutations
Mini-sequencing of genomic DNA from the patient revealed that PLCz H233L and PLCz H398P were heterozygous in nature (Fig. 4A ).
The patient's mother did not possess PLCz
H398P
, but was heterozygous for PLCz H233L . The father, however, was heterozygous for PLCz H398P
. Interestingly, the patient's daughter did not possess PLCz H398P , but was heterozygous for PLCz H233L . The patient's halfbrother did not possess either mutation (Fig. 4B ).
Genetic screening of the prevalence of H233L and H398P in a wider patient population
Single-nucleotide polymorphism (SNP) assays did not detect either PLCz H233L or PLCz H398P in 100 fertile individuals (200 chromosomes), or eight OAD patients (six patients with globozoospermia and abnormal sperm morphology and two patients exhibiting normal sperm morphology). SNP assays further confirmed that the patient, his mother and his daughter were all heterozygous for PLCz H233L , and that his half-brother and father do not carry the H233L mutation. However, analyses further confirmed that the patient's father is heterozygous for the H398P mutation (Fig. 5) .
Discussion
Increasing evidence suggests that dysfunctional forms of the oocyte activation factor PLCz may underlie certain types of male factor infertility, with accumulating evidence supporting the therapeutic use of PLCz to treat cases of OAD (Yoon et al., 2008; Heytens et al., 2009) . Taylor et al. (2010) recently showed that the micro-injection of OAD sperm expressing abnormal levels of PLCz, coincident with a Ca 2+ ionophore resulted in high rates of human oocyte activation, resulting in the birth of a healthy child. Collectively, these studies provide significant support for the clinical application of a recombinant active form of PLCz as a safer and more endogenous alternative to the artificial activating agents used at present. However, we still know relatively little as to how defective genetic mechanisms associated with PLCz may underlie some forms of OAD. The discovery of the H398P mutation in PLCz from a patient with OAD established the first link between PLCz mutation and human infertility (Heytens et al., 2009 ). However, the heterozygous nature of this mutation left unresolved the question of how this mutation could result in infertility (Heytens et al., 2009; Nomikos et al., 2011) , and the mode of inheritance associated with this mutation remained unknown.
A second novel mutation in PLCz
Using a modified version of the genetic screening method employed by Heytens et al. (2009) , the present study reports the identification and functional characterization of a novel second mutation (PLCz H233L ) from the same patient from whom PLCz H398P was first identified. Interestingly, while histidine is a polar and hydrophilic amino acid, leucine is a non-polar hydrophobic amino acid. Therefore, the PLCz H233L mutation is likely to disrupt local interactions within protein folding, in a manner similar to PLCz
H398P
. Indeed, 3D modelling predicts that the histidine at position 233 of the PLCz amino acid sequence may serve a critical role in the maintenance of protein structure by holding the adjacent protein helix in place, and/or stabilising the position of a loop at the bottom of its adjacent helix. , or its mouse equivalent H435P which totally abolished the ability of PLCz to trigger Ca 2+ oscillations in the mouse oocyte and prevented enzyme activity in a PIP2 hydrolysis assay (Nomikos et al., 2011) . While H398 is highly conserved among all known PLCz isoforms across a range of species (Heytens et al., 2009) , H233 is not (data not shown). However, considering the abnormal profile of Ca 2+ oscillations evident upon injection of PLCz H233L cRNA into mouse oocytes, which were insufficient for activation, it is clearly apparent that PLCz H233L may exert reduced functionality, or possibly reduced efficiency in substrate binding, indicating that both mutations contributed towards the patient's infertility. The discovery of PLCz H233L from the same patient implies that the contribution of mutated PLCz protein to the patient's infertile status is more complex than previously thought. We show that both mutations possess different parental origins, with PLCz H398P inherited from the patient's father, and PLCz H233L inherited from the mother. To our knowledge, this represents the first description of an autosomal point mutation to have been passed from a mother to her son, resulting in a deficit of sperm function and male infertility.
A maternally inherited mutation contributes to male infertility
While it is difficult to ascertain specific global causative factors for infertility, male factor and idiopathic (unknown) infertility are thought to be major contributors (each occurring in 28% of cases; Kashir et al., 2010) . Accumulating evidence suggests that abnormalities in testicular gene expression may contribute towards idiopathic male infertility (Kashir et al., 2010) . Major known causes of human male infertility include Y chromosome-linked abnormalities and microdeletions which are not associated with a particular syndrome, but lead to impaired spermatogenesis, and mutations in X chromosomelinked genes such as Akap4, Nxf2 and Tex11 involved in spermatogenesis (Wang and Pan, 2007; Zheng et al., 2010) . Due to the single copy, hemizygous nature of these genes, damaging mutations would not be masked by a normal allele (Zheng et al., 2010) . However, screening for X-linked gene mutations in infertile men has yet to reveal any causative factors (Zheng et al., 2010) . Furthermore, specific genes have not been identified for a number of autosomal male factor conditions. One such example is globozoospermia, an infertile condition involving round-headed and acrosome-less sperm, estimated to affect 0.1% of infertile men (Dam et al., 2007) . While numerous studies indicate that globozoospermia may be a multi-factorial genetic syndrome (Kullander and Rausing, 1975; Flörke-Gerloff et al., 1984; Dale et al., 1994; Kilani et al., 2004; Heindryckx et al., 2005) , the specific mode of inheritance remains unclear, although a mutation in the SPATA16 gene has been implicated (Dam et al., 2007) . One further example is the CFTR gene, thought to be mutated in 60 -90% of patients presenting with congenital bilateral absence of the vas deferens, a type of obstructive azoospermia (O'Flynn O'Brien et al., 2010) . While this may be considered a maternally inherited autosomal disorder, the problem in this case is abnormal testicular structure instead of a biochemical deficit. Inheritance profiles for mutant PLCz
Our data suggest that studies investigating the role of genes involved in male infertility should involve not only the father of an infertile male, but also the mother, since it now appears that infertile males may inherit mutated genes from either parent. Indeed, Sazci et al. (2005) described a case in which a son inherited a translocation (t(1;13)(q24;q10)) from his mother, associated with primary infertility in the son, but not the mother. This translocation was associated with a normal phenotype, but was theorized to affect meiosis during spermatogenesis, leading to azoospermia. While causing infertility, this was a chromosomal structural defect, and not an autosomal pointmutation as the one we report herein. Considering that many germ cell-specific genes are also localized at autosomes (Sazci et al., 2005) , our study serves to demonstrate that male infertility may be more multi-factorial and complex in nature than previously thought. Indeed, it seems apparent that PLCz mutations may contribute not only to male infertility but also to male sub-fertility.
Since the patient's daughter has inherited PLCz H233L , it is possible that if she has male progeny in future, they may also inherit the same mutation and thus experience sub-fertility. Furthermore, our study indicates that the incidence of both PLCz H233L and PLCz H398P is less than 1 in 100 individuals (200 chromosomes) within a general population, and the mutations were not identified in a small group of patients diagnosed with oocyte activation deficiency, suggesting that these particular mutations may be relatively rare, or even unique. However, the small size of the OAD patient population within this study is insufficient to draw specific conclusions regarding the prevalence of these two mutations within the general ICSI failed patient population, and future studies should attempt to recruit a much larger cohort of OAD patients. It is worth noting however, that six of these patients suffered from globozoospermia, a condition linked to a suspected genetic syndrome which results in the formation of sperm with abnormal morphology and without acrosomes (Dam et al., 2007) . It is therefore important that future mutation studies should predominantly target males exhibiting oocyte activation failure, without globozoospermia and exhibiting normal sperm morphology. Such studies should attempt to correlate genetic analysis to the specific pattern of PLCz localization in the sperm head. While Grasa et al. (2008) recently mapped the distribution of PLCz to acrosomal, equatorial and post-acrosomal regions of fertile human sperm, it remains possible that structural changes of the PLCz protein, occurring as a result of genetic mechanisms, may result in abnormal expression or localization patterns with associated functional deficit. Indeed, high-resolution immunogold electron microscopy studies have highlighted important roles for the acrosomal membrane and perinuclear acroplaxome in harbouring a large number of structural and functional proteins (Kierszenbaum et al., 2011) , mutations of which may lead to defective sperm function and male infertility.
Mutations in PLCz may function in a recessive manner
It is interesting to note that while the patient's father was heterozygous for PLCz H398P , the patient was conceived naturally without the use of ART. Since PLCz H398P and its mouse equivalent have been demonstrated to abolish the Ca 2+ inducing ability of PLCz (Heytens et al., 2009; Nomikos et al., 2011) , the natural conception of the patient demonstrates that loss of activity mutations in PLCz need to be present on both maternal and paternal alleles for complete infertility to occur. While speculative at this time, the most likely scenario by which sperm from the patient's father was able to successfully fertilize oocytes from the mother was if the fertilizing sperm contained normal PLCz protein in addition to PLCz H398P DNA.
Even though the first point of PLCz translation during human spermatogenesis has yet to be identified, recent studies indicate that PLCz is first detectable at the round spermatid stage in hamster ) and equine (Bedford-Guaus et al., 2011) models. The possible interchange of mRNA transcripts via cytoplasmic bridges in developing spermatids and spermatocytes may have led to the presence of functional WT PLCz protein within spermatids and spermatocytes containing mutant PLCz (Dadoune et al., 2004; Heytens et al., 2009) . It is also a possibility that PLCz transcription occurs throughout the meiotic phase of spermatogenesis, potentially resulting in mixed populations of PLCz transcripts derived from both maternal and paternal alleles (for reviews, see Eddy, 2002; Dadoune et al., 2004; Bettegowda and Wilkinson, 2010) .
In summary, we have identified a novel second mutation (PLCz H233L ) of the oocyte activation factor PLCz in an infertile patient, and demonstrate that both PLCz H233L and PLCz H398P mutations are likely to be rare. We propose that these mutations function in a recessive manner. Our findings demonstrate for the first time, that the maternal inheritance of autosomal point mutations in male-specific proteins may result in certain forms of male factor infertility, highlighting the importance of studying maternal inheritance within such conditions. Collectively, our findings not only further support the physiological importance of PLCz in the oocyte activation process, but also represent a considerable advancement in our understanding of the modes of inheritance of male infertility, and shed significant new light as to how such conditions may arise.
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